Cronos Group Inc. (CRON) shares reached a 52-week high of $3.44 on Monday, extending gains after the company reported second-quarter 2026 results that exceeded expectations.
The Toronto-based cannabis producer’s stock last traded at $3.43, up 3.51% for the session, according to live market data. Its market capitalization has risen to approximately $1.25 billion. Year-to-date, CRON shares have advanced 25.86%, while the past 12 months have seen a 31.08% increase.
Cronos reported Q2 2026 revenue of $53 million, ahead of analyst estimates of $44.73 million. Adjusted earnings per share came in at $0.09, compared with a projected $0.01. Gross profit reached a record $28.5 million, while adjusted EBITDA climbed to $13.1 million. Operating cash flow for the quarter totaled $24 million, and the company held $827 million in cash, equivalents, and investments at quarter-end.
During the quarter, Cronos repurchased $60 million of its stock, signaling confidence in its financial position. The company operates in Canada and Israel, with a focus on cannabis cultivation, production, and distribution. Analysts at InvestingPro have flagged the shares as currently overvalued relative to their fair value, despite the recent rally.
